Revvity | PKI - 負債





負債 変化する 日付
Agilent USD 3.35B 0 2025-12
Align Technology USD 114.45M 6.82M 2025-12
Bio Techne USD 200M 60M 2026-03
Bio-Rad Laboratories USD 1.39B 9.2M 2025-12
Bruker USD 2.04B 34.4M 2025-12
Celltrion KRW 161.31B 9.78B 2025-12
Charles River Laboratories USD 2.57B 58.23M 2025-12
Cspc Pharmaceutical CNY 495M 12.33M 2025-06
Danaher USD 18.48B 66M 2026-03
Dentsply International USD 2.33B 137M 2026-03
Deva Holding AS TRY 5.3B 871.93M 2023-09
Dianthus Therapeutics USD 1.28M 45K 2025-09
Divis Laboratories Ltd INR 40M 40M 2025-03
Edwards Lifesciences USD 600M 105.4M 2026-03
Illumina USD 2.55B 23M 2025-12
Intuitive Surgical USD 0 0 2025-03
IQVIA Holdings USD 15.83B 109M 2026-03
Kangmei Pharma CNY 173.71M 42.08M 2026-03
Knight Therapeutics CAD 77.91M 28.33M 2025-12
Laboratorios Farma EUR 129.3M 14.89M 2025-06
Laboratory Of America USD 6.53B 3.9M 2025-12
Malin Corporation EUR 100K 0 2023-12
Medical Developments International AUD 1.99M 152K 2025-06
Mesa Laboratories USD 204.98M 7.27M 2024-09
Mettler Toledo International USD 2.15B 57.69M 2025-12
Myriad Genetics USD 59.3M 19.7M 2025-03
Neuren Pharmaceuticals AUD 0 0 2024-12
OraSure Technologies USD 782K 465K 2024-06
Ovoca Bio EUR 0 0 2021-06
Pacific Biosciences Of California USD 892.24M 653K 2023-12
Pharma Mar EUR 47.54M 1.88M 2026-03
Qiagen NV USD 1.81B 314.82M 2025-12
Quest Diagnostics USD 6.41B 179M 2026-03
Quidel USD 2.83B 9.9M 2025-12
Repligen USD 546.58M 4.37M 2026-03
Revvity USD 3.4B 29.2M 2025-12
Sartorius EUR 4.28B 372.9M 2025-12
Sino Biopharmaceutical CNY 9.71B 33.98M 2024-12
Thermo Fisher Scientific USD 39.39B 3.7B 2025-12
Tilray USD 640.95M 35.17M 2022-06
Waters USD 1.49B 4.92M 2025-12
Zz Pientze Pharmaceu CNY 1.07B 2.82M 2026-03